ERJ
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Park, G.Y.
Right arrow Articles by Yoo, C.G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Park, G.Y.
Right arrow Articles by Yoo, C.G.
Eur Respir J 2001; 18:801-809
Copyright ©ERS Journals Ltd 2001


Anti-inflammatory effect of adenovirus-mediated I{kappa}B{alpha} overexpression in respiratory epithelial cells

G.Y. Park1, S. Lee1,2, K.H. Park1,2, C.T. Lee1,2,3, Y.W. Kim1,2,3, S.K. Han1,2,3, Y.S. Shim1,2,3 and C.G. Yoo1,2,3

1 Dept of Internal Medicine, Seoul National University College of Medicine, Chongno-Gu, Seoul, Korea. 2 Clinical Research Institute, Seoul National University Hospital, Chongno-Gu, Seoul, Korea. 3 Lung Institute, Seoul National University Medical Research Center, Chongno-Gu, Seoul, Korea

CORRESPONDENCE: C.G. Yoo, Dept of Internal Medicine, Seoul National University College of Medicine, 28 Yongon-Dong, Chongno-Gu, Seoul, 110-799, Korea. Fax: 82 27629662

Keywords: adenovirus, interleukin-;8, I{kappa}B{alpha} super-repressor, nuclear factor-{kappa}B, respiratory epithelial cells, tumour necrosis factor-;{alpha}

Received: November 28, 2000
This work was supported by the 1999 National Research and Development Programme (Ministry of Science and Technology).


    Abstract
 TOP
 Abstract
 Materials and methods
 Results
 Discussion
 Acknowledgements
 References
 
Many studies into basic biological characteristics of inflammation and tissue injury have implicated pro-inflammatory cytokine-mediated tissue injury in the pathogenesis of inflammatory lung diseases. Because transcription of most pro-inflammatory cytokines is dependent on the activation of nuclear factor (NF)-{kappa}B, NF-{kappa}B could be a good potential target to suppress the cytokine cascade. Cytokine-induced activation of NF-{kappa}B requires phosphorylation and subsequent degradation of I{kappa}Ba. Therefore, the blocking NF-{kappa}B activation by I{kappa}B{alpha} could inhibit the pro-inflammatory cytokine-induced tissue injury.

To evaluate whether blocking of NF-{kappa}B activation shows an anti-inflammatory effect, this study investigated the effect of adenovirus-mediated overexpression of I{kappa}B{alpha} super-repressor (I{kappa}B{alpha}-SR) on the pro-inflammatory cytokine expression in respiratory epithelial cells.

The transduction efficiency of adenovirus was >90% in both A549 and NCI-H157 cells. Ad5I{kappa}B{alpha}-SR-transduced cells expressed high levels of I{kappa}B{alpha}-SR, which was resistant to tumour necrosis factor (TNF)-;{alpha}-;induced degradation. Adenovirus-mediated overexpression of I{kappa}B{alpha}-SR blocked cytokine-induced nuclear translocation of p65 and NF-{kappa}B deoxyribonucleic acid binding activity without affecting total cellular expression level of NF-{kappa}B. Ad5I{kappa}B{alpha}-SR transduction suppressed cytokine-induced interleukin-;8 and TNF-;{alpha} expressions at both ribonucleic acid and protein levels.

These results suggest that blocking the nuclear factor-{kappa}B pathway by adenovirus-mediated overexpression of I{kappa}B{alpha}-super-repressor shows an effective anti-inflammatory effect in respiratory epithelial cells.

Nuclear factor (NF)-{kappa}B is an ubiquitous inducible transcription factor involved in immune, inflammatory, stress and developmental processes. It is sequestered in the cytoplasm in an inactive state by association with the inhibitory molecule I{kappa}B{alpha}. NF-{kappa}B is rapidly activated in response to various stimuli, including viral infection, lipopolysaccharide (LPS), ultraviolet irradiation, and pro-inflammatory cytokines such as tumour necrosis factor (TNF)-;{alpha} and interleukin (IL)-1ß 13. TNF-;{alpha} leads to the sequential activation of the downstream NF-{kappa}B-inducing kinase (NIK) and the recently isolated TNF-;{alpha}-;inducible I{kappa}B kinase complex (IKK) 48. When activated, IKK directly phosphorylates Ser32 and Ser36 of I{kappa}B{alpha}, triggering ubiquitination at Lys21 and Lys22, and rapid degradation of I{kappa}B{alpha} in 26S proteasome 13. This process liberates NF-{kappa}B, allowing it to translocate to the nucleus. In the nucleus, NF-{kappa}B binds to its cognate {kappa}B site and transactivates the downstream genes.

In inflammatory lung diseases, such as acute lung injury (ALI), pro-inflammatory cytokines, especially TNF-;{alpha} and IL-1ß, are known to be involved in tissue damage 9. Pro-inflammatory cytokines function in redundant and overlapping ways through the cytokine "cascade" or "network". As most genes for inflammatory mediators (such as TNF-;{alpha}, IL-;2, IL-;6, IL-;8, lymphotoxin, granulocyte macrophage-colony stimulating factor (GM-CSF), ß-;interferon, and adhesion molecules) have {kappa}B site in the 5' flanking region 13, the transcription of most pro-inflammatory cytokine genes are regulated by NF-{kappa}B activation. Therefore, NF-{kappa}B could be a good potential target to suppress the cytokine cascade.

NF-{kappa}B activation can be inhibited by blocking various points in the NF-{kappa}B/I{kappa}B pathway. One method of NF-{kappa}B inhibition is overexpression of I{kappa}B{alpha}. The overexpression of wild-type I{kappa}B{alpha} partially blocked NF-{kappa}B responsive gene expression in vitro 10, 11. Since wild type I{kappa}B{alpha} is degraded in response to inflammatory mediators which are present at the site of inflammation, overexpression of wild type I{kappa}B{alpha} would not be effective in blocking NF-{kappa}B activation. In order to block the activation of NF-{kappa}B effectively, I{kappa}B{alpha} should be resistant to degradation. Since inducible phosphorylation of I{kappa}B{alpha} at Ser32 and Ser36 is a critical step in the degradation of I{kappa}B{alpha}, I{kappa}B{alpha} mutants in which Ser32 and Ser36 are substituted with nonphosphorylatable alanine (I{kappa}B{alpha} super-repressor, I{kappa}B{alpha}-SR) are resistant to degradation.

The present study investigated the effect of blocking the activation of NF-{kappa}B by adenovirus-mediated overexpression of I{kappa}B{alpha}-SR on the pro-inflammatory cytokine expression in respiratory epithelial cells to evaluate the therapeutic potential of Ad5I{kappa}B{alpha}-SR in inflammatory lung diseases.


    Materials and methods
 TOP
 Abstract
 Materials and methods
 Results
 Discussion
 Acknowledgements
 References
 
Cells
A549 and NCI-H157 human respiratory epithelial cell lines were maintained in a monolayer in Roswell Park Memorial Institute (RPMI) 1640 containing 10% foetal bovine serum (FBS), penicillin (60 µg·mL–1), and streptomycin (100 µg·mL–1) at 37°C under 5% carbon dioxide (CO2).

Study design
Adenovirus vectors expressing I{kappa}B{alpha}-SR (Ad5I{kappa}B{alpha}-SR) and ß-;galactosidase (Ad5LacZ) were constructed. The transduction efficiency of adenovirus vector, its effect on the cell viability, and the stability of I{kappa}B{alpha}-SR were evaluated. The effect of adenovirus-mediated overexpression of I{kappa}B{alpha}-SR on the NF-{kappa}B activity and the pro-inflammatory cytokine expressions in respiratory epithelial cells were evaluated.

Methods
Transduction of adenoviruses
An adenovirus vector expressing I{kappa}B{alpha}-SR was constructed as previously described 12. A recombinant adenovirus expressing ß-;galactosidase gene was used as a control virus. Cells were transduced at multiplicities of infection (moi) of 20 by adenovirus vector in serum free RPMI for 1 h with gentle shaking and then washed with phosphate buffered saline (PBS) and incubated with growth medium at 37°C, 5% CO2 until use.

Analysis of cell viability
Cell viability was measured by a 3-;(4,5-dimethyl thiazol-;2-;yl)-2,5-diphenyl tetrazolium bromide (MTT) assay. MTT solution was added to cells in 96-well plates to the final concentration of 0.5 mg·mL–1, and cells were incubated at 37°C for 4 h. After removing culture media, 50 µL of dimethyl sulphoxide (DMSO) was added, and the optical density of each well was read at 590 nm.

Electrophoretic mobility shift assays
NF-{kappa}B deoxyribonucleic acid (DNA) binding activity was assessed as described previously 13. Briefly, nuclear extracts were incubated for 20 min at room temperature with radiolabelled NF-{kappa}B consensus sequence in the {kappa} light chain enhancer in B-;cells (5'-AGT TGA GGG GAC TTT CCC AGG C-3'). In competition experiments, 50-fold molar excess of unlabeled oligonucleotide was added to the binding reaction. In supershift experiments, anti-p65 or anti-p50 antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA) was added and allowed to react for 45 min at room temperature. DNA-protein complexes were resolved on 4% nondenaturing polyacrylamide gel. Gels were dried and autoradiographed at –70°C.

Western blot analysis
Cytoplasmic, nuclear, and whole cell extracts were prepared as described previously 13. Twenty micrograms of protein was resolved on 10% sodium dodecylsulphate-polyacrylamide gel electrophoresis (SDS-PAGE), and transferred to nitrocellulose. The membranes were blocked with 5% skim milk-PBS/0.1% Tween 20 for 1 h prior to overnight incubation at room temperature with rabbit polyclonal anti-p65 or anti-I{kappa}B{alpha} antibodies from Santa Cruz Biotechnology, diluted 1:1000 in 5% skim milk-PBS/0.1% Tween 20. Membranes were incubated with goat anti-rabbit horseradish peroxidase (HRP)-conjugated antibody (Promega, Madison, WI, USA), diluted 1:2000 in 5% skim milk-PBS/0.1% Tween 20 for 1 h. Following successive washes, membranes were developed with an enhanced chemoluminescence (ECL) kit (Amersham Pharmacia Biotech, Uppsala, Sweden).

Immunofluorescent staining for nuclear factor-{kappa}B
Cells grown in 2-;well chamber slides were fixed and permeabilized as described previously 13. Cells were incubated with rabbit polyclonal anti-p65 antibody, diluted 1:100 in 1% bovine serum albumin (BSA), for 30 min, and then incubated with rhodamine isothiocyanate-conjugated goat anti-rabbit immunoglobulin-;G antibody (Jackson ImmunoResearch, West Grove, PA, USA), diluted 1:100 in 1% BSA, for 30 min. Slides were analysed using a fluorescent light microscope.

Northern blot analysis
Total cellular ribonucleic acid (RNA) was isolated using TRIZOL Reagent (Gibco BRL, Gaithersburg, MD, USA). Equal amounts of total RNA (20 µg·lane–1) from each sample were loaded into each lane of 1.0% agarose/2% formaldehyde gel, and capillary transferred to a nylon membrane. The human complementary DNA (cDNA) for TNF-;{alpha} and IL-;8 (ATCC, Rockville, MD, USA) were radiolabelled with [{alpha}-32P]deoxycytidine triphosphate (dCTP) using a random priming kit (Stratagene, La Jolla, CA, USA). After prehybridizing the membranes for 2 h at 45°C in hybridization buffer, radiolabelled cDNA probe (1x106 cpm·mL–1 final concentration) was added and incubated overnight at 45°C. The membranes were exposed to X-;ray film (Eastman Kodak Co., Rochester, NY, USA) with intensifying screen for up to 5 days at –70°C.

Interleukin-;8 enzyme-linked immunosorbent assay
Cells (1x104) were grown in 96-well culture plates in equal numbers. The supernatants were collected and stored at –70°C until being analysed. IL-;8 concentrations were quantitated using enzyme-linked immunosorbent assay (ELISA) kit (R & D System, Minneapolis, MN, USA) according to the manufacturer's specifications.

Statistical analysis
All experiments were carried more than three times. The cell viability data were shown as mean±SD percentage of control of three different experiments. The ELISA data were reported as means±SD of three different experiments. Paired t-;tests were used for comparisons and a value of p<0.05 was considered as significant.


    Results
 TOP
 Abstract
 Materials and methods
 Results
 Discussion
 Acknowledgements
 References
 
Adenovirus efficiently transduces I{kappa}B{alpha} super-repressor gene into respiratory epithelial cells
The transduction efficiency of adenovirus vector in A549 cells was evaluated using a different adenovirus vector encoding ß-;galactosidase (Ad5LacZ) moi and observing the subsequent ß-;galactosidase staining. More than 90% of cells expressed ß-;galactosidase at the virus dose of 20 moi (fig. 1Go). To assess the adenovirus-mediated expression of I{kappa}B{alpha}-SR, Western blot analysis was performed with extracts of cells 48 h after infection with Ad5I{kappa}B{alpha}-SR. The exogenous I{kappa}B{alpha}-SR was heavily expressed compared to cells infected with Ad5LacZ (fig. 2aGo). To see the intracellular distribution of I{kappa}B{alpha}-SR, Western blot analysis was performed with cytoplasmic and nuclear extracts from Ad5LacZ or Ad5I{kappa}B{alpha}-SR transduced cells. While the endogenous I{kappa}B{alpha} was located mainly in the cytoplasm, some of the overexpressed I{kappa}B{alpha}-SR translocated to the nucleus (fig. 2bGo). In accordance with this observation, most cells expressed I{kappa}B{alpha}-SR in varying amounts both in the cytoplasm and nucleus in immunofluorescent staining (fig. 2cGo).



View larger version (82K):
[in this window]
[in a new window]
 
Fig. 1.— Transduction efficiency of adenovirus vector. A549 cells were infected with various doses of Ad5LacZ and stained for ß-;galactosidase 48 h after infection. a) Control; b) 5 multiples of infection (moi) Ad5LacZ; c) 10 moi; d) 20 moi; e) 50 moi; f) 100 moi.

 


View larger version (96K):
[in this window]
[in a new window]
 
Fig. 2.— Overexpression and subcellular localization of exogenous I{kappa}B{alpha} super-repressor (I{kappa}B{alpha}-SR) using adenoviral vectors in respiratory epithelial cells. a) Adenovirus-mediated overexpression of I{kappa}B{alpha}-SR. A549 and NCI-H157 cells were infected with Ad5LacZ or Ad5I{kappa}B{alpha}-SR at 20 multiples of infection (moi). Forty-eight hours after infection, whole cell extracts were separated by 10% sodium dodecylsulphate-polyacrylamide gel electrophoresis and transferred to nitrocellulose membranes, and I{kappa}B{alpha} was detected by rabbit polyclonal I{kappa}B{alpha} antibody. b) Subcellular localization of exogenous I{kappa}B{alpha}-SR. A549 cells were infected with Ad5LacZ or Ad5I{kappa}B{alpha}-SR. Cytoplasmic (C) and nuclear (N) extracts were assayed for I{kappa}B{alpha} by Western blot analysis 48 h after infection. c) and d) Cytoplasmic and nuclear localization of exogenous I{kappa}B{alpha}–SR. A549 cells were infected with c) Ad5LacZ or d) Ad5I{kappa}B{alpha}-SR. Immunofluorescent staining for I{kappa}B{alpha} was performed using I{kappa}B{alpha} antibody followed by rhodamine-conjugated detection antibody.

 
Adenovirus transduction does not affect cell survival
Excessive adenovirus infection itself may be cytotoxic. To evaluate this possibility, A549 and NCI-H157 cells were infected with Ad5LacZ or Ad5I{kappa}B{alpha}-SR. Cell viability was evaluated by MTT assay 24 and 48 h after infection. Cell viability did not change up to 48 h after infection, in both Ad5LacZ (A549: 96±5 at 24 h, 98±7 at 48 h; NCI-H157: 98±7 at 24 h, 93±9 at 48 h) and Ad5I{kappa}B{alpha}-SR (A549: 84±9 at 24 h, 84±6 at 48 h; NCI-H157: 94±9 at 24 h, 90±7 at 48 h) infected cells at adenovirus dose of 20 moi (data are shown as mean percentage of control±SD).

I{kappa}B{alpha} super-repressor is resistant to tumour necrosis factor-;{alpha}-;induced degradation
Since various pro-inflammatory cytokines are produced during an inflammatory process, exogenous I{kappa}B{alpha} should be resistant to cytokine-induced degradation in order to block NF-{kappa}B activation effectively at the site of inflammation. To investigate the stability of I{kappa}B{alpha}-SR, time dependent degradation of I{kappa}B{alpha} in response to TNF-;{alpha} stimulation was determined by Western blot analysis after transduction with Ad5LacZ or Ad5I{kappa}B{alpha}-SR. In Ad5LacZ infected cells, endogenous I{kappa}B{alpha} was completely degraded in 30 min, followed by resynthesis in 60 min in both A549 and NCI-H157 cells (fig. 3aGo). In contrast, stimulation of Ad5I{kappa}B{alpha}-SR infected cells with TNF-;{alpha} did not detectably decrease I{kappa}B{alpha}- SR protein levels (fig. 3bGo).



View larger version (45K):
[in this window]
[in a new window]
 
Fig. 3.— Exogenous I{kappa}B{alpha} super-repressor (I{kappa}B{alpha}-SR) is resistant to tumour necrosis factor (TNF)-;{alpha}-;induced degradation. A549 and NCI-H157 cells were infected with a) Ad5LacZ or b) Ad5I{kappa}B{alpha}-SR at 20 multiples of infection (moi) for 48 h, and then stimulated with TNF-;{alpha} (5 ng·mL–1) for 5, 30, 60, and 90 min. Whole cell extracts were assayed for I{kappa}B{alpha} by Western blot analysis.

 
Adenovirus-mediated gene transfer of I{kappa}B{alpha} super-repressor blocks tumour necrosis factor-;{alpha}-;induced nuclear factor-{kappa}B activation
The high level of nondegradable exogenous I{kappa}B{alpha}-SR expression in Ad5I{kappa}B{alpha}-SR infected cells suggests a potential inhibitory effect of I{kappa}B{alpha}-SR on the NF-{kappa}B activity. To test this possibility, NF-{kappa}B activity in Ad5LacZ and Ad5I{kappa}B{alpha}-SR infected cells was measured in response to TNF-;{alpha} stimulation. NF-{kappa}B activity was assayed by two approaches: first, by measuring the NF-{kappa}B-DNA binding activity by electrophoretic mobility shift assay (EMSA) and second by assessing the nuclear translocation of NF-{kappa}B subunit p65. To evaluate the effect of overexpression of I{kappa}B{alpha}-SR on the NF-{kappa}B-DNA binding activity, Ad5LacZ and Ad5I{kappa}B{alpha}-SR infected cells were stimulated with TNF-;{alpha} (5 ng·mL–1) for 30 min, and nuclear extracts were subjected to EMSA with {kappa}B site DNA probe. In Ad5LacZ-transduced cells, NF-{kappa}B-DNA binding activity increased in response to TNF-;{alpha} stimulation (fig. 4aGo). In contrast, this TNF-;{alpha}-;induced increase in NF-{kappa}B-DNA binding activity was completely blocked in Ad5I{kappa}B{alpha}-SR infected cells (fig. 4aGo). When 50-fold molar excess of unlabelled double-stranded NF-{kappa}B oligonucleotide was added to the binding reaction, the retarded band disappeared, suggesting the specificity of binding. Supershift assay showed the presence of p50 and p65 subunits of NF-{kappa}B. To confirm further that the nuclear translocation of transcriptionally active NF-{kappa}B subunit p65 was reduced by Ad5I{kappa}B{alpha}-SR transduction, cytoplasmic and nuclear extracts were assayed by Western blot analysis for changes in relative abundance of p65. In Ad5LacZ infected cells, the majority of p65 was located in the cytoplasmic fraction under basal state (fig. 4bGo). After 30 min of TNF-;{alpha} stimulation, a decrease in cytoplasmic p65 was noted with concomitant increase in nuclear p65. In contrast, nuclear p65 abundance was not observed in Ad5 I{kappa}B{alpha}-SR infected cells by TNF-;{alpha} stimulation (fig. 4bGo). The subcellular localization of p65, with or without TNF-;{alpha} stimulation, was also investigated by immunofluorescent staining. In Ad5LacZ infected cells, there was a strong nuclear staining of p65 after 30 min of TNF-;{alpha} stimulation compared to the cytoplasmic distribution in unstimulated cells. This nuclear translocation of p65 by TNF-;{alpha} was blocked in Ad5I{kappa}B{alpha}-SR infected cells, as demonstrated by the cytoplasmic staining pattern (fig. 4cGo). These results support the conclusion that Ad5I{kappa}B{alpha}-SR transduction suppresses NF-{kappa}B activation following stimulation with TNF-;{alpha}.



View larger version (57K):
[in this window]
[in a new window]
 
Fig. 4.— Adenovirus-mediated overexpression of I{kappa}B{alpha} super-repressor (I{kappa}B{alpha}-SR) blocks tumour necrosis factor (TNF)-;{alpha}-;induced activation of nuclear factor (NF)-{kappa}B. a) Effect of overexpression of I{kappa}B{alpha}-SR on NF-{kappa}B deoxyribonucleic acid (DNA) binding activity. A549 and NCI-H157 cells were infected with Ad5LacZ or Ad5I{kappa}B{alpha}-SR for 48 h, and then incubated for 30 min in the presence or absence of TNF-;{alpha} (5 ng·mL–1). Nuclear extracts were subjected to electrophoretic mobility shift assay with {kappa}B site DNA probe. b) Effect of overexpression of I{kappa}B{alpha}-SR on blocking of TNF-;{alpha}-;induced nuclear translocation of NF-{kappa}B subunit p65. Ad5LacZ or Ad5I{kappa}B{alpha}-SR-infected A549 cells were treated with media alone or TNF-;{alpha} (5 ng·mL–1) for 30 min and then cytoplasmic and nuclear extract were prepared. Cytoplasmic (C) and nuclear (N) extracts were analysed for the presence of p65 by Western blot analysis. c) Effect of overexpression of I{kappa}B{alpha}-SR on subcellular localization of p65. Ad5LacZ- or Ad5I{kappa}B{alpha}-SR-infected A549 cells were treated with media alone (control) or TNF-;{alpha} (5 ng·mL–1) for 30 min and then fixed and permeabilized for 5 min. Immunofluorescent staining for p65 was performed using anti-p65 antibody followed by a rhodamine-conjugated antibody.

 
Adenovirus-mediated gene transfer of I{kappa}B{alpha} super-repressor blocks pro-inflammatory cytokine expression
Since most inflammatory cytokine genes that play an important role in the inflammatory response contain functional NF-{kappa}B binding sites in their promoter regions, the effect of inhibition of NF-{kappa}B activation by adenovirus-mediated overexpression of I{kappa}B{alpha}-SR on the expression of inflammatory cytokines, both at mRNA and protein levels, have been analysed. At first, TNF-;{alpha}-;induced IL-;8 and IL-1ß-induced TNF-;{alpha} mRNA expressions were evaluated by Northern blot analysis in nontreated, and Ad5LacZ- and Ad5I{kappa}B{alpha}-SR-infected cells. In nontreated control and Ad5LacZ-infected cells, both TNF-;{alpha}-;induced IL-;8 and IL-1ß-induced TNF-;{alpha} mRNA expressions were significantly increased 4 h after TNF-;{alpha} or IL-1ß stimulation, which was completely inhibited in Ad5I{kappa}B{alpha}-SR-infected cells (fig. 5aGo). To evaluate the effect of I{kappa}B{alpha}-SR overexpression on the production of TNF-;{alpha}-;induced IL-;8 protein, IL-;8 protein concentration was measured by ELISA in culture supernatant, 18 h after stimulation with TNF-;{alpha}. The production of IL-;8 was significantly increased by TNF-;{alpha} stimulation in Ad5LacZ-infected cells. Ad5I{kappa}B{alpha}-SR transduction completely blocked TNF-;{alpha}-;induced IL-;8 production in both A549 and NCI-H157 cells (fig. 5bGo).



View larger version (54K):
[in this window]
[in a new window]
 
Fig. 5.— Adenovirus-mediated overexpression of I{kappa}B{alpha} super-repressor (I{kappa}B{alpha}-SR) blocks interleukin (IL)-1ß- and tumour necrosis factor (TNF)-induced pro-inflammatory cytokine expression. a) and b) Effect of exogenous I{kappa}B{alpha}-SR on pro-inflammatory cytokine messenger ribonucleic acid (mRNA) expression. A549 and NCI-H157 cells were infected with Ad5LacZ or Ad5I{kappa}B{alpha}-SR, then stimulated with a) TNF-;{alpha} (5 ng·mL–1) and b) IL-1ß (5 ng·mL–1) for 4 h. IL-1ß-induced TNF-;{alpha} mRNA, and TNF-;{alpha}-;induced IL-;8 mRNA expressions were assayed by Northern blot analysis. c) and d) Effect of exogenous I{kappa}B{alpha}-SR on the production of IL-;8. Ad5LacZ- or Ad5I{kappa}B{alpha}-SR-infected cells were stimulated with TNF-{alpha} for 18 h. Concentrations of IL-;8 in supernatant fluid were quantitated in c) A549 cells and d) NCI-H157 cells, by enzyme-linked immunosorbent assay (ELISA). {blacksquare}: nonstimulated cells; {square}: cells stimulated with TNF-;{alpha} (5 ng·mL–1 for 18 h). Data are presented as mean±sd of three different experiments. *: p<0.05 versus Ad5LacZ.

 

    Discussion
 TOP
 Abstract
 Materials and methods
 Results
 Discussion
 Acknowledgements
 References
 
The present study investigated the effect of overexpression of I{kappa}B{alpha}-SR, using an adenovirus vector, on the pro-inflammatory cytokine expression in respiratory epithelial cells. It was found that adenovirus-mediated overexpression of I{kappa}B{alpha}-SR suppressed the cytokine-induced activation of NF-{kappa}B. Ad5I{kappa}B{alpha}-SR transduction suppressed cytokine-induced IL-;8 and TNF-;{alpha} expressions at both RNA and protein levels. These results suggest that blocking the NF-{kappa}B pathway by adenovirus-mediated overexpression of I{kappa}B{alpha}-SR shows an effective anti-inflammatory effect in respiratory epithelial cells.

The present study constructed an adenovirus vector-expressing nondegradable I{kappa}B{alpha} to block NF-{kappa}B activation. Adenovirus vectors have advantages over other viral vector systems. Because an adenovirus does not integrate into chromosomal DNA, it poses a reduced risk for cellular transformation caused by insertional mutagenesis or activation of endogenous retroviruses. An adenovirus also has the capacity for expression of relatively large DNA inserts (up to 7 kb), the ability to be propagated easily and purified to high titres, an extremely broad host range, and the availability of a large number of vectors containing different promoters 14. In addition, in contrast to retroviral vectors, which can express transduced genes only in proliferating cells with relatively low efficiency, adenovirus vectors can express their gene products with much higher efficiency in dividing, nondividing, or slowly proliferating cells, without prolonged in vitro culture or selection 15, 16. To assay the inhibitory effect of I{kappa}B{alpha} on the expression of endogenous genes, and to allow biochemical analysis, it is necessary to utilize a highly efficient transfection system. Adenovirus-mediated gene transfer meets this criterion 1720. In this study, the transduction efficiency was >90% and I{kappa}B{alpha}-SR was highly expressed in both A549 and NCI-H157 cells. Adenoviral gene therapy is particularly applicable to the respiratory system because of its easy accessibility by bronchoscopy or inhalation.

There is evidence that I{kappa}B{alpha}, which is resynthesized after degradation, can enter the nucleus and remove NF-{kappa}B from DNA. The inactive NF-{kappa}B-I{kappa}B{alpha} complex is then transported back into the cytoplasm, thereby completing a cycle of activation and inactivation of NF-{kappa}B 2123. In the present study, some of the over-expressed I{kappa}B{alpha}-SR translocated to the nucleus whereas the endogenous I{kappa}B{alpha} remained in the cytoplasm. This observation suggests that over-expressed I{kappa}B{alpha}-SR suppressed the function of activated NF-{kappa}B in addition to sequestering NF-{kappa}B in the cytoplasm.

Excessive adenovirus infection itself is cytotoxic. In addition, overexpression of I{kappa}B{alpha}-SR alone resulted in increased cytotoxicity in lung cancer cells 24. To evaluate whether the decreased pro-inflammatory cytokine production after transduction with Ad5I{kappa}B{alpha}-SR may be due to a cytotoxic effect of adenovirus infection, cell viability was assessed by MTT assay at 24 and 48 h after adenovirus infection. Neither Ad5LacZ nor Ad5I{kappa}B{alpha}-SR transduction decreased cell viabilities of A549 or NCI-H157 cells, up to 48 h, at a dose of 20 moi, minimizing the possibility of a cytotoxic effect of Ad5I{kappa}B{alpha}-SR in these experiments. This is not consistent with a previous study by Batra et al. 24, which showed a marked decrease in cell viability by Ad5I{kappa}B{alpha}-SR transduction. One factor that may contribute to this discrepancy is the dose of adenovirus. In contrast to 20 moi used in the present study, cells were transduced at 100 moi in the Batra et al. 24 study.

Respiratory epithelial cells are the main target of injury in various inflammatory lung diseases. In addition, respiratory epithelial cells are actively involved in initiating and maintaining inflammation by producing pro-inflammatory mediators. This inflammatory process delays the normal epithelial cell repair following lung injury, which is critical for restoration of lung function. For these reasons, suppression of the inflammatory response in respiratory epithelial cells seems to be a prerequisite for accelerating the repair process in inflammatory lung diseases. In this study, both TNF-;{alpha}-;induced IL-;8 and IL-;1ß-induced TNF-;{alpha} expressions were inhibited at the mRNA and protein levels in Ad5I{kappa}B{alpha}-SR-infected respiratory epithelial cells compared to Ad5LacZ-infected cells. Because TNF-;{alpha} and IL-1ß are both chemotactic and mitogenic for lung fibroblasts and stimulate collagen synthesis by these cells 25, the inhibition of NF-{kappa}B activation with Ad5I{kappa}B{alpha}-SR may be an effective gene therapy for various inflammatory lung diseases, by suppressing both inflammation and fibrosis. In animal studies, intravenous somatic gene transfer with I{kappa}B{alpha} reduced endotoxin-induced activation of inflammatory mediators and increased survival 26. However, there are many problems that need to be solved before gene therapy can be widely used in clinical settings. First, an efficient method of delivering the adenoviral vector into the respiratory epithelial cells should be developed. In addition, host immunological responses against viral vector proteins need to be modulated to allow long-term exogene expression 27, 28.

In diverse cell types, NF-{kappa}B has been shown to regulate the apoptotic program, either as essential for the induction of apoptosis or, perhaps more commonly, as blockers of apoptosis. This depends on the specific cell type and the type of inducer. For example, in respiratory epithelial cells, the inhibition of NF-{kappa}B activation by Ad5I{kappa}B{alpha}-SR made NCI-H157 cells more susceptible to TNF-;{alpha}-;induced apoptosis 12, but not in A549 cells (data not shown). Therefore, TNF-;{alpha}, which is released in large amounts from inflammatory cells, may induce apoptosis in cells with adenovirus-mediated overexpression of I{kappa}B{alpha}-SR at the regional inflammation site. This may decrease the usefulness of Ad5I{kappa}B{alpha}-SR as a therapeutic tool to manage the excessive inflammation. The development of specific and safe NF-{kappa}B inhibitors, which does not impair NF-{kappa}B dependent normal cell functions, would be necessary for the effective suppression of inflammation.

In conclusion, the present data suggest the feasibility of adenovirus-mediated overexpression of I{kappa}B{alpha} super-repressor to suppress the inflammatory response in respiratory epithelial cells. Because there is no evidence that adenovirus-mediated overexpression of I{kappa}B{alpha} super-repressor would be effective in vivo, additional studies are needed to determine the effectiveness of this approach in lung inflammation in vivo.


    Acknowledgements
 TOP
 Abstract
 Materials and methods
 Results
 Discussion
 Acknowledgements
 References
 
The authors thank A.S. Baldwin (University of North Carolina, Chapel Hill, NC, USA) for providing I{kappa}B{alpha}-SR cDNA, and R.D. Gerard (University of Texas Southwestern Medical Center, Dallas, TX) for providing pAC-CMVpLpA and pJM17. The authors also thank S. Kim for proofreading this manuscript.


    References
 TOP
 Abstract
 Materials and methods
 Results
 Discussion
 Acknowledgements
 References
 

  1. Baldwin AS. The NF-{kappa}B and I{kappa}B proteins: new discoveries and insights. Annu Rev Immunol 1996;14:649–681.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  2. Barnes PJ, Karin M. Nuclear factor-{kappa}B – a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 1997;336:1066–1071.[Free Full Text]
  3. Ghosh S, May MJ, Kopp EB. NF-{kappa}B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 1998;16:225–260.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  4. DiDonato JA, Hayakawa M, Rothwarf DM, Zandi E, Karin M. A cytokine-responsive I{kappa}B kinase that activates the transcription factor NF-{kappa}B. Nature 1997;388:548–554.[CrossRef][Medline] [Order article via Infotrieve]
  5. Mercurio F, Zhu H, Murray BW, et al. IKK-;1 and IKK-;2: cytokine-activated I{kappa}B kinases essential for NF-{kappa}B activation. Science 1997;278:860–866.[Abstract/Free Full Text]
  6. Regnier CH, Song HY, Gao X, Goeddel DV, Cao Z, Rothe M. Identification and characterization of an I{kappa}B kinase. Cell 1997;90:373–383.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  7. Woronicz JD, Gao X, Cao Z, Rothe M, Goeddel DV. I{kappa}B kinase-;ß: NF-{kappa}B activation and complex formation with I{kappa}B kinase {alpha} and NIK. Science 1997;278:866–869.[Abstract/Free Full Text]
  8. Zandi ED, Rothwarf M, Delhase M, Hayakawa M, Karin M. The I{kappa}B kinase complex (IKK) contains two kinase subunits, IKK{alpha} and IKKß, necessary for I{kappa}B phosphorylation and NF-{kappa}B activation. Cell 1997;91:243–252.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  9. Parsons PE. Mediators and mechanisms of acute lung injury. Clin Chest Med 2000;21:467–476.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  10. Goodman DJ, von Albertini MA, McShea A, Wrighton CJ, Bach FH. Adenoviral-mediated overexpression of I kappa B alpha in endothelial cells inhibits natural killer cell-mediated endothelial cell activation. Transplantation 1996;62:967–972.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  11. Wrighton CJ, Hofer-Warbin R, Moll T, Eytner R, Bach FH, de Martin R. Inhibition of endothelial cell activation by adenovirus-mediated expression of I kappa B alpha, an inhibitor or the transcription factor NF kappa B. J Exp Med 1996;183:1013–1022.[Abstract/Free Full Text]
  12. Kim JY, Lee S, Hwangbo B, et al. NF-{kappa}B activation is related to the resistance of lung cancer cells to TNF-;{alpha}-;induced apoptosis. Biochem Biophys Res Commun 2000;273:140–146.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  13. Yoo CG, Lee S, Lee CT, Kim YW, Han SK, Shim YS. Anti-inflammatory effect of heat shock protein induction is related to stabilization of I{kappa}B{alpha} through preventing I{kappa}B kinase activation in respiratory epithelial cells. J Immunol 2000;164:5416–5423.[Abstract/Free Full Text]
  14. Graham FL, Prevec L. Manipulation of adenovirus vectors. Gene transfer and expression protocols In: Murray E, ed. Methods in Molecular BiologyClifton, Humana Press, Inc., 1991; pp. 109–128.
  15. Berkner KL. Development of adenovirus vectors for the expression of heterologous genes. Biotechniques 1988;6:616–629.[ISI][Medline] [Order article via Infotrieve]
  16. Tang DC, Johnston SA, Carbone DP. Tumor-restricted gene expression by adenovirus-mediated gene transfer. Cancer Gene Ther 1994;1:15–20.[ISI][Medline] [Order article via Infotrieve]
  17. Chen SJ, Wilson JM, Muller DW. Adenovirus-mediated gene transfer of soluble vascular cell adhesion molecule to porcine interposition vein grafts. Circulation 1994;89:1922–1928.[Abstract/Free Full Text]
  18. Lemarchand P, Jaffe HA, Danel C, et al. Adenovirus-mediated transfer of a recombinant human a1-antitrypsin cDNA to human endothelial cells. Proc Natl Acad Sci USA 1992;89:6482–6486.[Abstract/Free Full Text]
  19. Morsy MA, Alford EL, Bett A, Graham FL, Caskey CT. Efficient adenoviral-mediated ornithine transcarbamylase expression in deficient mouse and human hepatocytes. J Clin Invest 1993;92:1580–1586.
  20. Ohno T, Gordon D, San H, et al. Gene therapy for vascular smooth muscle cell proliferation after arterial injury. Science 1994;265:781–784.[Abstract/Free Full Text]
  21. Arenzana-Seisdedos F, Turpin P, Rodriguez M, et al. Nuclear localization of I{kappa}B{alpha} promotes active transport of NF-{kappa}B from the nucleus to the cytoplasm. J Cell Sci 1997;110:369–378.[Abstract]
  22. Zabel U, Baeuerle PA. Purified human I{kappa}B can rapidly dissociate the complex of the NF-{kappa}B transcription factor with its cognate DNA. Cell 1990;61:255–265.[CrossRef][ISI][Medline] [Order article via Infotrieve]
  23. Zabel U, Henkel T, dos Santos Silva M, Baeuerle PA. Nuclear uptake control of NF-kappa B by MAD-;3, an I kappa B protein present in the nucleus. EMBO J 1993;12:201–211.[ISI][Medline] [Order article via Infotrieve]
  24. Batra RK, Guttridge DC, Brenner DA, Dubinett SM, Baldwin AS, Boucher RC. I{kappa}B{alpha} gene transfer is cytotoxic to squamous-cell lung cancer cells and sensitized them to tumor necrosis factor-;{alpha}-;mediated cell death. Am J Respir Cell Mol Biol 1999;21:238–245.[Abstract/Free Full Text]
  25. McAnulty RJ, Laurent GJ. Pathogenesis of lung fibrosis and potential new therapeutic strategies. Exp Nephrol 1995;3:96–107.[ISI][Medline] [Order article via Infotrieve]
  26. Böhrer H, Qiu F, Zimmermann T, et al. Role of NF{kappa}B in the mortality of sepsis. J Clin Invest 1997;100:972–985.[ISI][Medline] [Order article via Infotrieve]
  27. Gahery-Degard H, Molinier-Frenkel V, Le Boulaire C, et al. Phase 1 trial of recombinant adenovirus gene transfer in lung cancer. J Clin Invest 1997;100:2218–2226.[ISI][Medline] [Order article via Infotrieve]
  28. Yei S, Mittereder N, Wert S, Whitserr JA, Wilmott RW, Trapnell BC. In vivo evaluation of the safety of adenovirus-mediated transfer of the human cystic fibrosis transmembrane conductance regulator cDNA to the lung. Hum Gene Ther 1994;5:731–744.[ISI][Medline] [Order article via Infotrieve]




This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via ISI Web of Science (7)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Park, G.Y.
Right arrow Articles by Yoo, C.G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Park, G.Y.
Right arrow Articles by Yoo, C.G.


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS